DERM (DERM)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$173.56M
EV / Sales2.68
EV / EBITDA-120.36
EV / Operating Cash Flow-25.90
EV / Free Cash Flow-25.90

Return Metrics (TTM)

Return on Equity (ROE)-35.57%
Return on Assets (ROA)-10.47%
Return on Invested Capital (ROIC)-11.26%
Return on Capital Employed (ROCE)-11.81%

Yield Metrics

Earnings Yield-5.51%
Free Cash Flow Yield-3.82%

Balance Sheet Strength

Net Debt / EBITDA1.21
Current Ratio1.72
Working Capital$27.14M
Tangible Asset Value$4.35M
Net Current Asset Value$4.26M

Working Capital Efficiency

Days Sales Outstanding141.03
Days Payables Outstanding123.64
Operating Cycle (Days)273.48
Cash Conversion Cycle149.84

Capital Allocation

CapEx / Revenue0.00%
CapEx / Operating Cash Flow0.00%
R&D / Revenue0.68%
SG&A / Revenue49.25%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin59.29%
Operating Margin-13.21%
Net Profit Margin-18.48%

Solvency

Debt / Equity0.80
Quick Ratio1.53
Cash Ratio0.64

Per Share

Revenue / Share$2.53
FCF / Share-$0.51
PE Ratio-16.40